
29 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Enns, Medical Biochemical Geneticist in Palo Alto, CA?
Dr. Gregory Enns, MD is a Medical Biochemical Geneticist, who primarily practices in Palo Alto, CA with 1 additional practice location. He has been practicing for over 29 years and is board certified. Dr. Enns graduated from University of St. Andrews School of Medicine and completed his residency at Children'S Hosp Of L A, Pediatrics. Dr. Enns is fluent in English, and is currently seeing new patients. Dr. Enns’s practice accepts Kaiser Permanente, Medicare, Aetna, Cigna, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Enns’s office at (650) 497-8000.
What are Areas of Expertise for Dr. Enns?
Dr. Gregory Enns, MD is a highly-rated, board-certified Medical Biochemical Geneticist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Enns empowers patients to confidently navigate their health journey, specializing in Inherited Metabolic Disorders, Marfan Syndrome, Mitochondrial Disorders, and comprehensive wellness support. Serving the Palo Alto, CA community, Dr. Enns is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Enns go to medical school and complete their residency?
Residency: Children'S Hosp Of L A, Pediatrics | Children's Hospital Of L A | Children's Hospital Program
Medical School: University of Glasgow Faculty of Medicine | University of St. Andrews School of Medicine | University of Glasgow Faculty of Medicine
Is Dr. Enns board certified as a Medical Biochemical Geneticist?
Yes, Dr. Gregory Enns, MD is board certified by the American Board of Medical Genetics , American Board of Pediatrics
What languages does Dr. Enns speak?
Dr. Enns and their clinical team can communicate with patients in the following languages:
English
What conditions does a Medical Biochemical Geneticist like Dr. Enns typically treat?
As a Medical Biochemical Geneticist, Dr. Enns diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Enns. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Phenylketonuria (PKU)
- High Phenylalanine Levels
- Phenylketonuria
- Metabolic Disorder
- Tetrahydrobiopterin deficiency
- PKU
- Følling's Disease
- Phenylalanine Hydroxylase Deficiency
- Hyperphenylalaninemia
- Phenylalanine Metabolism Disorder
ICD-10 Codes:
- E700: Classical phenylketonuria
- E701: Other hyperphenylalaninemias
Also known as:
- Other Specific B Vitamin Deficiency
- B Vitamins
- Malnutrition
- Specific B Vitamin Shortage
- Less Common B Vitamin Deficiency
- Rare B Vitamin Deficiency
ICD-10 Codes:
- E538: Deficiency of other specified B group vitamins
Also known as:
- Lysine and Hydroxylysine Metabolism Disorder
- Amino Acid Metabolism Disorder
- Hyperlysinemia
- Lysine Processing Problems
- Genetic Lysine Disorder
ICD-10 Codes:
- E723: Disorders of lysine and hydroxylysine metabolism
Also known as:
- Medium-Chain Acyl-CoA Dehydrogenase Deficiency
- Lipid Metabolism Disorder
- Medium-chain acyl-CoA dehydrogenase deficiency
- MCAD Deficiency
- Medium-Chain Fatty Acid Oxidation Disorder
- MCADD
ICD-10 Codes:
- E71311: Medium chain acyl CoA dehydrogenase deficiency
What procedures does a Medical Biochemical Geneticist like Dr. Enns typically perform?
As a Medical Biochemical Geneticist, procedures performed by Dr. Gregory Enns may include:
- Biochemical Genetics Consultation
- Biochemical Genetics Follow Up
- Enzyme Replacement Therapy
- Genetic Testing
- Metabolic Assessment and Management
Please contact Dr. Enns' office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Enns accept my insurance?
Dr. Enns accepts most major insurance plans. Important: Please call our office at (650) 497-8000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Enns accept in Palo Alto, CA?
Dr. Enns in Palo Alto, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
Blue Shield of California
California Water Service Group
Cigna Group
CVS Health (formerly Aetna)
Medicare
Molina Healthcare
Santa Cruz County
State of California
UMR Administered Payer
UnitedHealth Group
View All Insurances
Where is Dr. Enns' office located?
What hospitals are Dr. Enns affiliated with?
Castle Connolly Top Hospital
This doctor is affiliated with a Castle Connolly Top Hospital.
Dr. Enns has admitting privileges at the following hospitals:
Stanford Health Care - Stanford Hospital,Stanford, CA
Ranked in 6 Procedures

Ranked in 6 Procedures
Stanford Medicine Children’s Health,Palo Alto, CA
Recognitions
Publications
A new LC-MS/MS method for the clinical determition of reduced and oxidized glutathione from whole
, 2013
Brain uptake of Tc99m
, 2012
Leigh syndrome caused by a novel m.4296G > A mutation in mitochondrial tR isoleucine
, 2012
Initial experience in the treatment of inherited mitochondrial disease with EPI-743
, 2012
High-quality D sequence capture of 524 disease candidate genes
, 2011
Novel Deoxyguanosine Kise Gene Mutations
, 2009
Mapping Gene Associations in Human Mitochondria using Clinical Disease Phenotypes
, 2009
Inherited disorders affecting mitochondrial function are associated with glutathione deficiency
, 2009
Survival after treatment with phenylacetate and benzoate for urea-cycle disorders
, 2007
Molecular-clinical correlations in a family with variable tissue mitochondrial D T8993G mutant load
, 2006
Relationship of primary mitochondrial respiratory chain dysfunction to fiber type abnormalities
, 2005
The contribution of mitochondria to common disorders
, 2003
Mitochondrial respiratory chain complex I deficiency with clinical
, 2000
Liver transplantation for urea cycle disorders in pediatric patients: A single-center experience
, 2013
Atypical Amyoplasia Congenita in an Infant With Leigh Syndrome
, 2012
Propionic acidemia: To liver transplant or not to liver transplant?
, 2012
tural history of propionic acidemia
, 2012
Length of pretal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants
, 2011
alpha-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging
, 2011
Long-term follow-up of a patient with early onset CBLG disease
, 2011
Suboptimal outcomes in patients with PKU treated early with diet alone: Revisiting the evidence
, 2010
Long-term outcome following pediatric liver transplantation for metabolic disorders
, 2010
Nitrogen sparing therapy revisited 2009
, 2010
Pathological evidence of Wolman's dise
, 2009
Hypoplastic Glomerulocystic Kidney Disease
, 2009
A novel homozygous SCO2 mutation, p.G193S, causing fatal infantile cardioencephalomyopathy
, 2009
Successful pregncy and cesarean delivery via noninvasive ventilation in mitochondrial myopathy
, 2009
Neurologic Damage and Neurocognitive Dysfunction in Urea Cycle Disorders
, 2008
Cell-based therapies for metabolic liver disease
, 2008
Central nervous system therapy for lysosomal storage disorders
, 2008
Glutaric acidemia type I: a neurosurgical perspective
, 2007
Systemic hyalinosis: A distinctive early childhood
, 2006
Genitopatellar syndrome: Expanding the phenotype and excluding mutations in LMX1B and TBX4
, 2006
Glutaryl-CoA dehydrogese deficiency and newborn screening
, 2005
Magement of methylmalonic acidaemia by combined liver-kidney transplantation
, 2005
Postpartum psychosis in mild argininosuccite synthetase deficiency
, 2005
Identification of three novel mutations
, 2005
Mild developmental delay in termil chromosome 6p deletion
, 2004
Termil 22q deletion syndrome
, 2004
Head imaging abnormalities in dihydropyrimidine dehydrogese deficiency
, 2004
Methotrexate/misoprostol embryopathy: Report of four cases resulting from failed medical abortion
, 2003
Compensatory amplification of mtD in a patient with a novel deletion
, 2003
Congenital disorder of glycosylation Ic in patients of Indian origin
, 2003
Clinical and molecular features of congenital disorder of glycosylation in patients with type 1
, 2002
The adolescent with an inborn error of metabolism: medical issues and transition to adulthood.
, 2002
Early neotal diagnosis of long-chain 3-hydroxyacyl coenzyme A dehydrogese
, 2002
Functiol alysis of novel mutations
, 2001
Clinical course and biochemistry of sialuria
, 2001
Molecular correlations in phenylketonuria
, 1999
Apparent cyclophosphamide (cytoxan) embryopathy: A distinct phenotype?
, 1999
Progressive neurological deterioration
, 1999
Severe congenital anomalies requiring transplantation in children with Kabuki syndrome
, 1998
Congenital diaphragmatic defects and associated syndromes, malformations
, 1998